Connect with us

Technology

Days After Launch, Attunio Health Expands Precision Psychiatry Infrastructure with Quest Diagnostics and Getlabs

Published

on

Quest Diagnostics and Getlabs strengthen Attunio’s AI-powered, biomarker-driven infrastructure with blood and genetic testing from home

ATLANTA, June 25, 2026 /PRNewswire/ — Just days after publicly launching its AI-powered precision psychiatry platform and gaining early media attention, Attunio Health announced a major expansion of its clinical infrastructure by selecting Quest Diagnostics as its national laboratory backbone and integrating Getlabs for at-home blood collection.

The announcement marks another significant milestone in Attunio’s rapid growth as the company builds what it believes is the future of mental healthcare: continuous, objective, data-driven care powered by artificial intelligence, biomarkers, and real-world patient signals.

While traditional psychiatry has long relied on subjective symptom reporting, episodic visits, and trial-and-error medication management, Attunio is building a fundamentally different model.

The firm’s system merges:

Clinical insights provided through artificial intelligence.

Physiological information collected by devices worn on the human body.

Examination of blood biomarkers

Examination of genetic material.

The observation of behavior.

Medical professional-directed therapy enhancement.

This infrastructure powers what Attunio calls Closed-Loop Precision Psychiatry™ — a model in which psychiatric treatment is continuously informed by evolving biological and behavioral data rather than limited to occasional appointments.

With Quest Diagnostics serving as Attunio’s national laboratory backbone, the platform can support scalable access to advanced diagnostic testing across the United States.

These diagnostic capabilities help clinicians identify biological contributors to mental health impairment, including:

Impaired metabolic function

Persistent inflammation

Lack of essential vitamins and nutrients.

A state of disrupted hormonal equilibrium.

Drug processing and indicators of safety.

Measures of neurobiological performance

Attunio has also integrated Getlabs to enable blood and genetic testing from home, allowing certified mobile phlebotomists to travel directly to patients’ homes or workplaces for specimen collection.

This dramatically reduces friction in diagnostic testing and makes biomarker-driven psychiatric care more accessible to patients nationwide.

By combining diagnostic testing with wearable data and AI analysis, Attunio aims to help clinicians answer critical questions traditional psychiatric visits often cannot:

Is declining focus caused by ADHD progression or poor sleep?

Is worsening anxiety linked to physiological stress or metabolic dysfunction?

Is medication underperforming due to biology, genetics, or adherence?

Can deterioration be detected before a patient reaches crisis?

As interest accelerates around AI in healthcare, digital biomarkers, and precision medicine, Attunio is positioning itself at the intersection of psychiatry, diagnostics, and artificial intelligence.

The company believes mental healthcare must evolve beyond reactive care.

The future, Attunio says, will be:

Predictive. Measurable. Personalized.

This latest infrastructure expansion builds on Attunio’s recent launch, which introduced a new model of behavioral healthcare centered on wearable data, biomarker analysis, and AI-powered clinical intelligence designed to improve outcomes for conditions such as ADHD, anxiety, depression, and cognitive burnout.

About Attunio Health

“Attunio Health is deeply committed to advancing health and wellness, striving to deliver innovative solutions that make a tangible difference in people’s lives every day. Our dedication extends beyond mere treatment, focusing on proactive care and fostering healthier communities across the region and beyond.” To learn more visit https://www.attuniohealth.com/marketplace

View original content to download multimedia:https://www.prnewswire.com/news-releases/days-after-launch-attunio-health-expands-precision-psychiatry-infrastructure-with-quest-diagnostics-and-getlabs-302811003.html

SOURCE Attunio Health

Continue Reading

Technology

LEAP Group Relaunches HumanView, a Growth Intelligence System Built to Explain Why Customers Behave the Way They Do

Published

on

By

Reimagined from the ground up, HumanView pairs statistical modeling with expert analysts to turn millions of real-world customer signals into business decisions

LOUISVILLE, Ky., Oct. 23, 2026 /PRNewswire/ — LEAP Group today announced the relaunch of HumanView, its growth intelligence service. The new version has been rebuilt from the ground up and now has a dedicated home at leapgroupnetwork.com/humanview.

HumanView analyzes what customers say and do across social platforms, e-commerce sites, review platforms, search behavior and user-generated content, including signals from Reddit, TikTok, YouTube, Meta, Amazon and Walmart+ that general AI tools cannot always access. Because the data reflects unprompted, real-world behavior, it avoids the response bias built into surveys and focus groups.

The service works in three layers. HumanView captures signals at scale, decodes millions of records through validated statistical models such as regression, correlation and clustering, and then relies on experienced analysts to interpret the patterns. Clients receive clear, human-validated insights instead of another dashboard.

“Machines find the patterns. Humans find the point,” said Alan Gilleo, CEO at LEAP Group. “The first version of HumanView showed us how much customers reveal when nobody is asking them questions. This version is built to explain why they act the way they do, and to put those answers in front of everyone making decisions, from product to service to marketing.”

HumanView focuses on three areas:

Growth Intelligence: customer motivations and how people perceive a brand and its competitors

Market and Category Intelligence: product pain points, service friction, unmet needs and competitive gaps

Audience Intelligence: new segments, positioning opportunities and gaps in the market

Every model is designed and validated by data scientists and benchmarked before it informs a recommendation.

To learn more about HumanView, visit leapgroupnetwork.com/humanview.

About LEAP Group
LEAP Group is a boutique marketing agency holding company with offices in Louisville, Indianapolis, Cincinnati and Chicago. Guided by the belief that brands should “Market Less. Matter More.,” LEAP gives clients access to specialized experts across its entire network. Learn more at leapgroupnetwork.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/leap-group-relaunches-humanview-a-growth-intelligence-system-built-to-explain-why-customers-behave-the-way-they-do-302918557.html

SOURCE LEAP Group

Continue Reading

Technology

STEPHEN A. SMITH ADDRESSES WHITE HOUSE DINNER ATTENDANCE, REAFFIRMS COMMITMENT TO HBCUs AND PROTECTING CORPORATE INVESTMENT IN BLACK EDUCATION

Published

on

By

NEW YORK, Oct. 23, 2026 /PRNewswire/ — Stephen A. Smith, media mogul, New York Times bestselling author, and proud 1991 graduate of Winston-Salem State University, is addressing the public discussion surrounding his decision to attend a White House dinner with President Donald Trump, emphasizing his commitment to the long-term financial stability of Historically Black Colleges and Universities (HBCUs).

For Smith, the decision was rooted in a commitment to institutions that have educated generations of Black leaders, professionals, entrepreneurs, and public servants.

“I will always advocate for HBCUs and the students whose futures depend on them,” Smith said. “My reason for attending the White House dinner was to discuss the challenges these institutions face in securing long-term funding and to make the case that corporate America must continue to invest in them.”

Smith acknowledged federal support through the FUTURE Act while expressing concern that political tensions surrounding diversity, equity, and inclusion (DEI) could discourage private companies from supporting HBCUs. He maintains that these institutions deserve sustained corporate partnerships, philanthropic contributions, and public investment.

“If we truly believe in free-market capitalism, businesses should be able to support educational institutions and charitable causes without fear of criticism or repercussions,” Smith said. “HBCUs have made extraordinary contributions to this country. They deserve sustained public and private investment.”

Ashley Christopher, Esq., Founder and CEO of the HBCU Week Foundation, recognized Smith’s advocacy and decision to engage with the administration.

“Stephen A. Smith has been a powerful advocate for HBCUs, using his platform and influence to shine a national spotlight on our institutions,” expressed Christopher, “His continued support of HBCU Week helps advance our mission of connecting students with life-changing educational opportunities, and we are proud to have him as our ambassador.”

Since Smith became an HBCU Week Ambassador in 2019, the initiative has facilitated more than 15,000 on-the-spot college acceptances and raised and awarded more than $150 million in scholarships, according to the HBCU Week Foundation.

As public discussion continues, Smith is emphasizing the importance of ensuring HBCUs have the resources and partnerships needed to educate future generations and expand opportunities for students.

CLICK HERE to watch Smith’s full response to his White House visit.

MEDIA CONTACT:

media@mrsasinc.com

View original content:https://www.prnewswire.com/news-releases/stephen-a-smith-addresses-white-house-dinner-attendance-reaffirms-commitment-to-hbcus-and-protecting-corporate-investment-in-black-education-302918547.html

SOURCE Straight Shooter Media

Continue Reading

Technology

Advantex Announces Completion of Financing and Extension of Maturity Date of Previously Issued Debentures

Published

on

By

TORONTO, Oct. 23, 2026 /CNW/ — Advantex Marketing International Inc. (CSE: ADX) (“Advantex”), a leader in the merchant cash advance and loyalty marketing products for merchants, today announced the completion of a $250,000 secured debt financing. Advantex issued a $250,000 non-convertible debenture which bears an interest rate at 12% per annum and matures December 15, 2027. The proceeds raised from this issuance of the Debenture will be used for working capital purposes.

Advantex has also extended the maturity of its existing $700,000 in 12% secured debentures from October 10, 2026 to December 15, 2027.

About Advantex Marketing International Inc.

Advantex provides working capital to merchants. Advantex also provides specialized marketing programs that enable members of Aeroplan to earn Aeroplan points at participating merchants.

Advantex shares trade on the Canadian Securities Exchange under the symbol ADX. For more information go to Advantex’s profile on www.sedar.com

Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of applicable securities laws relating to the future business and operations of Advantex. Actual results and developments may differ materially from those contemplated by these statements. The business and operations of Advantex described herein is dependent on a number of factors and is subject to a number of risks and uncertainties. Factors that could cause actual results to differ material include, but are not limited to, changes in Advantex’s economic and competitive conditions including but not limited to the industry sectors in which Advantex operates.

The statements in this news release are made of the date of this release. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and Advantex undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law.

SOURCE Advantex Marketing International Inc.

Continue Reading

Trending